Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2

Chen, YL; Huang, F; Xuan, L; Zhang, Y; Fan, ZP; Xu, N; Zhao, K; Xu, J; Liu, H; Shi, PC; Wang, ZX; Sun, J; Zheng, WY; Dai, M; Liu, QF

Dai, M; Liu, QF (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, 1838 Guangzhou Blvd North, Guangzhou, Peoples R China.

INTERNATIONAL JOURNAL OF CANCER, 2021; 149 (5): 1109

Abstract

Whether patients with myelodysplastic syndrome (MDS) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) benefit from pretranspl......

Full Text Link